Healthcare

Functional Longevity Summit Dallas 2026 Aims to Bridge Clinical Innovation with Practice Sustainability

Functional Longevity Summit Dallas 2026 Aims to Bridge Clinical Innovation with Practice Sustainability

The upcoming Functional Longevity Summit in Dallas focuses on equipping healthcare providers with practical strategies to implement precision medicine and regenerative therapies while building financially sustainable practices.

April 22, 2026
SmileHQ Launches Comprehensive Family Dental Practice in Washington D.C.

SmileHQ Launches Comprehensive Family Dental Practice in Washington D.C.

SmileHQ has opened as a full-service family dental practice in Washington D.C., consolidating general, cosmetic, orthodontic, and oral surgery care in one location to reduce coordination burdens for families managing multiple dental needs.

April 22, 2026
Alliance Pavers Partners with M/I Homes for 2026 Pelotonia Cancer Research Home Build in Orlando

Alliance Pavers Partners with M/I Homes for 2026 Pelotonia Cancer Research Home Build in Orlando

Alliance Pavers joins M/I Homes to construct a designated Pelotonia Home in Orlando, directing funds toward cancer research and local charities while matching donations to amplify community impact.

April 22, 2026
New Pediatric Dental Practice Addresses Critical Gap in Spanish Fort's Children's Healthcare

New Pediatric Dental Practice Addresses Critical Gap in Spanish Fort's Children's Healthcare

Malbis Parkway Pediatric Dentistry has opened in Spanish Fort, Alabama, providing essential specialized dental care for children and addressing a significant local shortage that forced families to travel for treatment.

April 22, 2026
Revesby Health Hub Launches Flexible Coworking Space for Western Sydney Practitioners

Revesby Health Hub Launches Flexible Coworking Space for Western Sydney Practitioners

My Health Network has opened a 170-square-meter multidisciplinary coworking facility in Revesby, offering independent health practitioners flexible, all-inclusive consulting rooms without long-term lease commitments while fostering cross-referral networks.

April 22, 2026
Blue Sky Scrubs Launches Classic Scrub Pants Line Engineered for Healthcare Professionals' Demands

Blue Sky Scrubs Launches Classic Scrub Pants Line Engineered for Healthcare Professionals' Demands

Blue Sky Scrubs has introduced a durable classic scrub pants collection designed specifically to withstand the physical demands of healthcare environments during extended shifts, addressing critical needs for comfort and longevity in medical workwear.

April 22, 2026
Tonix Pharmaceuticals Publishes Pharmacokinetic Study Supporting TONMYA's Mechanism for Fibromyalgia Treatment

Tonix Pharmaceuticals Publishes Pharmacokinetic Study Supporting TONMYA's Mechanism for Fibromyalgia Treatment

Tonix Pharmaceuticals' peer-reviewed study demonstrates TONMYA's superior pharmacokinetic profile compared to oral cyclobenzaprine, supporting its use as the first new fibromyalgia treatment in over 15 years.

April 22, 2026
Canadian Scientists Identify Brain Cells That Fuel Glioblastoma Growth

Canadian Scientists Identify Brain Cells That Fuel Glioblastoma Growth

Researchers have discovered that certain brain cells previously thought to be passive support structures actively promote glioblastoma tumor growth, potentially opening new therapeutic avenues for one of the deadliest forms of brain cancer.

April 22, 2026
Polyrizon Secures $3.5 Million in Funding to Advance Intranasal Protective Technology

Polyrizon Secures $3.5 Million in Funding to Advance Intranasal Protective Technology

Polyrizon Ltd. has raised $3.5 million through a registered direct offering and private placement to fund development of its nasal spray hydrogel technology designed to create protective barriers against viruses and allergens.

April 22, 2026
Kairos Pharma Recognized for Innovation in Overcoming Cancer Drug Resistance

Kairos Pharma Recognized for Innovation in Overcoming Cancer Drug Resistance

Kairos Pharma Ltd. has been honored with the 2026 Pinnacle Award for its pioneering work on resistance-modulating treatments that aim to enhance the effectiveness of existing cancer therapies.

April 22, 2026
Earth Science Tech Inc. Expands Healthcare Portfolio Through Strategic Holdings

Earth Science Tech Inc. Expands Healthcare Portfolio Through Strategic Holdings

Earth Science Tech Inc. is building a diversified healthcare platform through strategic acquisitions and active management of compounding pharmacies, telehealth services, and community-focused healthcare providers, aiming to create sustainable growth and shareholder value.

April 22, 2026
Analytical Validation Strengthens Soligenix Outlook as Pipeline Advances

Analytical Validation Strengthens Soligenix Outlook as Pipeline Advances

A recent Zacks Small-Cap Research report highlights Soligenix's clinical progress and upcoming milestones, particularly in its phase 3 FLASH2 trial for cutaneous T-cell lymphoma treatment, reinforcing the company's strategic credibility and valuation potential.

April 22, 2026
Compact Proton Therapy Systems Promise Greater Accessibility for Cancer Patients

Compact Proton Therapy Systems Promise Greater Accessibility for Cancer Patients

Innovative compact proton therapy systems are reducing equipment size and costs, potentially making this precise cancer treatment more accessible to patients who previously couldn't access it due to traditional systems' limitations.

April 22, 2026
Nutriband CEO Discusses AVERSA Technology's Role in Addressing Opioid Crisis on Podcast

Nutriband CEO Discusses AVERSA Technology's Role in Addressing Opioid Crisis on Podcast

Nutriband Inc. CEO Gareth Sheridan highlighted the company's AVERSA abuse-deterrent transdermal technology on a podcast, emphasizing its potential to reduce misuse of high-risk drugs like fentanyl while maintaining patient access.

April 22, 2026
Earth Science Tech Inc. Expands Multi-Platform Healthcare Strategy Through Strategic Holdings

Earth Science Tech Inc. Expands Multi-Platform Healthcare Strategy Through Strategic Holdings

Earth Science Tech Inc. is building a diversified healthcare portfolio through strategic acquisitions and management of compounding pharmacies, telemedicine platforms, and specialized healthcare providers to create sustainable growth and shareholder value.

April 22, 2026
Jacksonville Family Transforms Type 1 Diabetes Diagnosis Into Advocacy Through Community Initiative

Jacksonville Family Transforms Type 1 Diabetes Diagnosis Into Advocacy Through Community Initiative

A Jacksonville family's journey with their son's Type 1 diabetes diagnosis has evolved into Pablo's Pack T1D, a community initiative providing resources and support while participating in the Breakthrough T1D Walk to advance research toward a cure.

April 22, 2026
GeoVax Advances Mpox/Smallpox Vaccine Toward Phase 3 Trial Amid Global Supply Concerns

GeoVax Advances Mpox/Smallpox Vaccine Toward Phase 3 Trial Amid Global Supply Concerns

GeoVax Labs is preparing to initiate a pivotal Phase 3 trial for its GEO-MVA vaccine in the second half of 2026, addressing critical global supply constraints for orthopoxvirus vaccines while reporting a reduced net loss of $21.5 million for 2025.

April 22, 2026
Oncotelic Therapeutics Exemplifies Biotech Sector's Shift Toward Pipeline-Driven Valuation

Oncotelic Therapeutics Exemplifies Biotech Sector's Shift Toward Pipeline-Driven Valuation

Oncotelic Therapeutics illustrates how biotechnology companies are increasingly being valued based on clinical progress and pipeline assets rather than traditional metrics, representing a fundamental shift in sector valuation practices.

April 22, 2026
Functional Longevity Summit Dallas 2026 to Bridge Gap Between Medical Innovation and Clinical Practice

Functional Longevity Summit Dallas 2026 to Bridge Gap Between Medical Innovation and Clinical Practice

The Functional Longevity Summit Dallas 2026 introduces a new model for medical education by providing practical implementation training in precision medicine and regenerative therapies to help healthcare providers improve patient outcomes while optimizing practice performance.

April 22, 2026
BioElectronics Expands ActiPatch to Taiwan Through Aphrodite Medical Group Partnership

BioElectronics Expands ActiPatch to Taiwan Through Aphrodite Medical Group Partnership

BioElectronics Corporation's expansion of its FDA-cleared ActiPatch device to Taiwan through distributor Aphrodite Medical Group represents a significant shift toward drug-free pain management alternatives in Asian healthcare markets.

April 22, 2026
Aclarion Authorizes $2.5 Million Stock Buyback, Signaling Confidence in Nociscan Growth

Aclarion Authorizes $2.5 Million Stock Buyback, Signaling Confidence in Nociscan Growth

Aclarion's board-approved share repurchase program highlights the company's disciplined capital management and belief that its stock is undervalued despite the ongoing clinical adoption of its Nociscan platform for chronic back pain diagnosis.

April 22, 2026
Catalyst Crew Technologies Launches Telehealth Platform Targeting Latin American Healthcare Gaps

Catalyst Crew Technologies Launches Telehealth Platform Targeting Latin American Healthcare Gaps

Catalyst Crew Technologies has launched its telehealth platform in Venezuela, aiming to address infrastructure constraints and fragmented care delivery across Latin America through AI-driven healthcare coordination.

April 22, 2026
Personalized mRNA Vaccine Shows Promise in Extending Pancreatic Cancer Survival

Personalized mRNA Vaccine Shows Promise in Extending Pancreatic Cancer Survival

A personalized mRNA vaccine has demonstrated potential to meaningfully extend survival for pancreatic cancer patients, according to six-year trial results presented at a major oncology conference.

April 22, 2026
Biotech Valuations Shift as Scientific Progress Gains Financial Recognition

Biotech Valuations Shift as Scientific Progress Gains Financial Recognition

The biotechnology industry is undergoing a transformation where scientific advancement is increasingly quantified as financial assets through fair-value accounting, with companies like Oncotelic Therapeutics demonstrating how clinical progress translates to tangible economic value.

April 22, 2026
Aclarion Secures U.S. Patent for AI-Driven Chronic Back Pain Assessment Technology

Aclarion Secures U.S. Patent for AI-Driven Chronic Back Pain Assessment Technology

Aclarion has obtained a U.S. patent for its AI-powered platform that analyzes spinal data to identify sources of chronic low back pain, potentially improving surgical outcomes and expanding access to more consistent diagnostics.

April 22, 2026
Memory Beads Inspired by 116-Year-Old's Habit Launch to Support Alzheimer's Research

Memory Beads Inspired by 116-Year-Old's Habit Launch to Support Alzheimer's Research

A new tactile brain health tool called Peter's Memory Beads, inspired by a 116-year-old man's daily routine, has launched with all proceeds supporting Alzheimer's Association research and services.

April 22, 2026
Catalyst Crew Technologies Advances Telehealth Platform Development for Latin American Markets

Catalyst Crew Technologies Advances Telehealth Platform Development for Latin American Markets

Catalyst Crew Technologies is developing an AI-integrated telehealth platform focused on emerging markets, starting with Venezuela, to improve healthcare coordination and data-driven insights in regions with growing demand for modernized medical services.

April 22, 2026
Helus Pharma Appoints Neuroscience Veteran Dr. Ken Kramer as Senior Vice President of Medical Affairs

Helus Pharma Appoints Neuroscience Veteran Dr. Ken Kramer as Senior Vice President of Medical Affairs

Helus Pharma's appointment of Dr. Ken Kramer, a 20-year neuroscience medical affairs leader, strengthens the company's clinical development capabilities for its novel serotonergic agonists targeting depression and anxiety disorders.

April 22, 2026
Oncotelic Therapeutics Reports $249 Million Net Income for FY 2025 Driven by Joint Venture Valuation

Oncotelic Therapeutics Reports $249 Million Net Income for FY 2025 Driven by Joint Venture Valuation

Oncotelic Therapeutics announced a dramatic financial turnaround with $249 million net income for fiscal year 2025, primarily due to a non-cash gain from its GMP Biotechnology joint venture valuation, signaling potential growth in its oncology and COVID-19 drug pipeline.

April 22, 2026
NextPlat's PharmcoRx Deploys AI Technology to Automate Pharmacy Prescription Processing

NextPlat's PharmcoRx Deploys AI Technology to Automate Pharmacy Prescription Processing

NextPlat Corp's PharmcoRx subsidiary has implemented AI-powered prescription intake and processing technology to automate manual workflows, improve efficiency, reduce costs, and support scalable growth in pharmacy management.

April 22, 2026
PreviousPage 7 of 78Next